Stivarga: payments to doctors
Payments that named Stivarga as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 8,754
- Transactions
- 28,462
- Average per transaction
- $73
The per-transaction average — $73 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,754 providers the average total is $237, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bayer | $2,057,620 | 99.2% |
| Bayer Puerto Rico Inc. | $16,158 | 0.8% |